FindTrial
Sign In

ROCEPHINE 1 g/3

DRUG3 trials

Sponsors

Institut Pasteur, Assistance Publique Hopitaux De Marseille, Centre Hospitalier Universitaire De Lille

Conditions

Bacterial vaginosisHigh risk preterm birth pregnancyHurley stage 2 active Hidradenitis SuppurativaPatients (male or female) ≥18 years old with Detrusor overactivity (DO) in multiple sclerosis (MS) or spinal cord injured (SCI).Vaginal flora abnormalities

Phase 3

A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradenitis Suppurativa Patients versus Tetracycline Derivative (ABCESS2)
RecruitingCTIS2023-505818-16-00
Institut PasteurHurley stage 2 active Hidradenitis Suppurativa
Start: 2025-05-22Target: 92Updated: 2026-01-15
ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoing intra-vesical botulinum toxin A injections
Not yet recruitingCTIS2024-515107-19-00
Centre Hospitalier Universitaire De LillePatients (male or female) ≥18 years old with Detrusor overactivity (DO) in multiple sclerosis (MS) or spinal cord injured (SCI).
Target: 526Updated: 2025-11-10
AUTOP 2 : Screen-and-treat strategy for vaginal flora abnormalities by molecular biology in pregnant women at high risk of preterm birth: A Multicentre, Randomized Study
Not yet recruitingCTIS2023-509421-41-03
Assistance Publique Hopitaux De MarseilleBacterial vaginosis, High risk preterm birth pregnancy, Vaginal flora abnormalities
Target: 1794Updated: 2026-04-01